Relmada Therapeutics
RLMD
#8408
Rank
ยฃ0.21 B
Marketcap
ยฃ2.00
Share price
-15.76%
Change (1 day)
-38.58%
Change (1 year)

Earnings for Relmada Therapeutics (RLMD)

Earnings in 2026 (TTM): -ยฃ46.4 Million

According to Relmada Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ43.87 Million, an increase over its 2024 earnings that were of -ยฃ61.14 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Relmada Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ46.4 Million5.76%
2025 -ยฃ43.87 Million-28.25%
2024 -ยฃ61.14 Million-19.04%
2023 -ยฃ75.52 Million-37.09%
2022 -ยฃ0.13 Billion24.88%
2021 -ยฃ96.13 Million111.5%
2020 -ยฃ45.45 Million296.24%
2019 -ยฃ11.48 Million-12.05%
2018 -ยฃ13.05 Million183.21%
2017 -ยฃ4.61 Million-23.25%
2016 -ยฃ6 Million-235.74%
2015 ยฃ4.41 M
2013 -ยฃ0.04 Million144.12%
2012 -ยฃ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-ยฃ0.6 Billion 1,156.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
ยฃ33.42 M-170.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel